October 2014

Do you have difficulty talking to physicians, nurses, or laboratory staff when you're trying to get an answer for a CIBMTR form question? 


Nurses around the world have been trained to use a communication technique called SBAR (Situation, Background, Assessment, and Recommendation) as an effective way to relay information. Likewise, this same technique could help data managers to effectively communicate with their transplant center medical staff.


To convey a clear message in simple steps, use this order:

  • S ituation -Briefly describe the issue.
  • Background -Explain factual data with examples to help your listener have the necessary information to be able to answer you. 
  • Assessment -Provide your own quick analysis.
  • Recommendation -Be prepared to give a recommendation if needed to resolve the situation.
Train yourself to say only the most relevant information during the conversation. Gather all the pertinent information and practice beforehand. Then, deliver your information in the same order each time. The staff will become familiar with your informational style and be less likely to interrupt you as you talk.  

Click on the videos to the right to watch an example of this technique now and what a difference it makes! (each about one minute long).

CIBMTR Training

CIBMTR is a research collaboration between the NMDP/Be The Match 

and Medical College of Wisconsin.






2400: Pre-TED
2014: MDS/MPN
2006: HCT Infusion

Center Specific Audit Summaries (Audit Cycle 4)

The CIBMTR Audit Cycle 4 (2010 - 2013) is now closed and center-specific audit summaries have been generated. For all centers audited during this time frame, the medical director (and the primary data manager) will receive a letter, information sheet, and the audit summary via e-mail in the upcoming weeks. The audit summary includes each center's audit results through Cycle 4 as well as graphical representations of audit results and a comparison to all other centers audited during this time. If you have any questions regarding your center's audit summary, please contact Deb Christianson, Senior Manager - Auditing and Monitoring, at dchristi@nmdp.org (612) 362-3426.

Have you registered yet?
New eLearning - Baseline 2000 Form

Click Here
to preview this training module right now (approximately 16 minutes in length).

This module will also be found in the Learning Management System (in about two weeks) under the Catalog for CIBMTR Data Management. Topics include:
  1. Ethnicity and Race
  2. Baseline Dependent Forms
  3. Form Sections
  4. Socioeconomic questions
Site Visits

This year we once again had the opportunity to conduct site visits at fifteen transplant centers with our theme being "Data Sharing." The main goals of the site visits are to gather information on how and when centers use CIBMTR data and to learn from centers how we can improve the data sharing process.  Information gathered during the site visits will help us develop strategies to improve access to data, and improve turn-around time for delivering data back to centers. The strategies that are developed will help us set a road-map for the future. We will be sharing our findings and this plan at the 2015 Tandem CRP/DM conference.


If we have not had the chance to visit with you and you would like to make a comment about your center's needs for Data Sharing with any ideas for improvement, please email:  CIBMTR Training









Question:  The definition of progression on Form 2116 uses the wording 'definite increase' when referring to the size of an existing bone lesion. How do we report progression of disease for a Myeloma patient who has a 'slight increase'?  



We consulted with CIBMTR's Myeloma expert who stated that a slight increase in the bone lesion alone would not count as progression. Below is an exerpt from the Form 2116 Manual that lists the requirements for reporting a patient's disease status as Progressive Disease:


Progressive Disease requires two or more of the following:



Progressive Disease reporting requires two consecutive assessments (by the same method) made at any time before classification as disease progression and/or the start of a new therapy.

Send your questions into CIBMTRTraining@nmdp.org . The answer may be in a future newsletter.
Thank you to the contributors for this month's newsletter.

CIBMTR Training